Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

GU Cancers 2025 | What are the benefits of mobile testing for prostate cancer?

Masood Moghul • 13 Feb 2025

GU Cancers 2025

Genitourinary Cancer Prostate Cancer

Man Van

Masood Moghul, MBBS, The Royal Marsden NHS Foundation Trust, London, UK, comments on the impact of mobile Man Van testing, stating that it helps facilitate access to healthcare, particularly for men from underserved populations, and notes that a wider rollout could significantly increase access to healthcare for these men. This interview took place at the ASCO GU Cancers Symposium 2025 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

The future of mobile testing for prostate cancer screening

The future of mobile testing for prostate cancer screening

Masood Moghul • 13 Feb 2025

The Man Van: mobile case finding for prostate cancer and health checks

The Man Van: mobile case finding for prostate cancer and health checks

Masood Moghul • 13 Feb 2025

Related Videos

Treatment sequencing after EV plus pembrolizumab in metastatic bladder cancer

Treatment sequencing after EV plus pembrolizumab in metastatic bladder cancer

Tian Zhang • 1 Jun 2026

Highlights in ADCs for bladder cancer at ASCO 2026

Highlights in ADCs for bladder cancer at ASCO 2026

Tian Zhang • 1 Jun 2026

EV plus pembrolizumab improves perioperative outcomes in muscle-invasive bladder cancer

EV plus pembrolizumab improves perioperative outcomes in muscle-invasive bladder cancer

Tian Zhang • 1 Jun 2026

Drug repurposing and trial challenges in rare renal medullary carcinoma

Drug repurposing and trial challenges in rare renal medullary carcinoma

Pavlos Msaouel • 30 May 2026